2016

1. The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: Results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

   Rheumatology (United Kingdom), Vol. 55, Núm. 11, pp. 2033-2039